Chongqing Zhifei Biological Products Co., Ltd.
SZSE:300122.SZ
56.53 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 52,679.018 | 38,264.011 | 30,652.416 | 15,190.366 | 10,587.318 | 5,228.308 | 1,342.569 | 445.947 | 712.738 | 800.938 | 780.178 | 764.62 | 628.74 | 737.314 | 604.047 | 590.336 | 492.429 |
Cost of Revenue
| 38,742.229 | 25,395.5 | 15,621.801 | 9,268.009 | 6,135.815 | 2,364.93 | 288.062 | 35.219 | 141.765 | 310.793 | 308.055 | 338.252 | 250.586 | 269.306 | 188.504 | 214.853 | 207.377 |
Gross Profit
| 13,936.789 | 12,868.512 | 15,030.615 | 5,922.357 | 4,451.503 | 2,863.378 | 1,054.507 | 410.728 | 570.973 | 490.144 | 472.123 | 426.368 | 378.154 | 468.008 | 415.543 | 375.483 | 285.052 |
Gross Profit Ratio
| 0.265 | 0.336 | 0.49 | 0.39 | 0.42 | 0.548 | 0.785 | 0.921 | 0.801 | 0.612 | 0.605 | 0.558 | 0.601 | 0.635 | 0.688 | 0.636 | 0.579 |
Reseach & Development Expenses
| 968.472 | 854.161 | 552.626 | 299.65 | 169.551 | 142.942 | 78.381 | 58.894 | 58.266 | 39.038 | 33.258 | 21.774 | 22.808 | 15.183 | 0 | 0 | 0 |
General & Administrative Expenses
| 110.59 | 94.353 | 92.521 | 67.462 | 56.017 | 37.794 | 27.935 | 26.974 | 16.725 | 29.868 | 37.592 | 29.744 | 27.138 | 13.16 | 42.034 | 31.232 | 14.065 |
Selling & Marketing Expenses
| 2,772.628 | 2,235.237 | 1,834.807 | 1,197.507 | 1,095.58 | 765.317 | 317.099 | 203.672 | 239.142 | 210.639 | 148.978 | 148.84 | 129.537 | 115.241 | 105.804 | 108.943 | 83.754 |
SG&A
| 3,450.396 | 2,329.59 | 1,927.328 | 1,264.969 | 1,151.598 | 803.111 | 345.034 | 230.647 | 255.867 | 240.506 | 186.571 | 178.584 | 156.675 | 128.4 | 147.838 | 140.175 | 97.819 |
Other Expenses
| -311.994 | 382.208 | 239.839 | 187.664 | 154.618 | -20.429 | -7.559 | 7.016 | 10.275 | 3.226 | 3.351 | 36.511 | 39.067 | 9.023 | 2.825 | 1.002 | -0.078 |
Operating Expenses
| 4,730.862 | 3,565.959 | 2,719.792 | 1,752.284 | 1,475.767 | 1,058.764 | 506.993 | 361.517 | 369.723 | 329.32 | 309.647 | 240.651 | 215.739 | 176.24 | 157.751 | 149.57 | 105.051 |
Operating Income
| 9,205.926 | 8,758.38 | 11,999.973 | 3,895.083 | 2,813.515 | 1,712.647 | 512.24 | 28.783 | 220.628 | 172.073 | 149.678 | 219.725 | 191.166 | 293.906 | 257.513 | 221.38 | 185.568 |
Operating Income Ratio
| 0.175 | 0.229 | 0.391 | 0.256 | 0.266 | 0.328 | 0.382 | 0.065 | 0.31 | 0.215 | 0.192 | 0.287 | 0.304 | 0.399 | 0.426 | 0.375 | 0.377 |
Total Other Income Expenses Net
| 136.367 | -40.372 | -68.918 | -41.011 | -48.137 | -112.396 | -42.833 | -13.475 | 29.436 | 14.424 | -9.729 | 70.487 | 67.803 | 11.158 | 2.902 | -3.773 | 5.489 |
Income Before Tax
| 9,342.293 | 8,718.008 | 11,931.055 | 3,854.072 | 2,765.378 | 1,692.218 | 504.681 | 35.737 | 230.687 | 175.248 | 152.747 | 256.204 | 230.217 | 302.925 | 260.694 | 222.139 | 185.49 |
Income Before Tax Ratio
| 0.177 | 0.228 | 0.389 | 0.254 | 0.261 | 0.324 | 0.376 | 0.08 | 0.324 | 0.219 | 0.196 | 0.335 | 0.366 | 0.411 | 0.432 | 0.376 | 0.377 |
Income Tax Expense
| 1,272.425 | 1,179.008 | 1,722.506 | 552.745 | 398.939 | 240.851 | 72.406 | 3.216 | 33.285 | 27.244 | 22.399 | 38.26 | 33.834 | 46.137 | 29.105 | 32.088 | 33.481 |
Net Income
| 8,069.868 | 7,539 | 10,208.548 | 3,301.327 | 2,366.439 | 1,451.367 | 432.275 | 32.52 | 197.402 | 148.004 | 130.348 | 217.944 | 196.384 | 256.788 | 231.59 | 190.051 | 152.009 |
Net Income Ratio
| 0.153 | 0.197 | 0.333 | 0.217 | 0.224 | 0.278 | 0.322 | 0.073 | 0.277 | 0.185 | 0.167 | 0.285 | 0.312 | 0.348 | 0.383 | 0.322 | 0.309 |
EPS
| 3.36 | 3.14 | 4.25 | 1.38 | 0.99 | 0.6 | 0.18 | 0.013 | 0.078 | 0.062 | 0.052 | 0.088 | 0.08 | 0.11 | 0.1 | 0.086 | 0.068 |
EPS Diluted
| 3.36 | 3.14 | 4.25 | 1.38 | 0.99 | 0.59 | 0.18 | 0.013 | 0.078 | 0.062 | 0.052 | 0.088 | 0.08 | 0.11 | 0.1 | 0.086 | 0.068 |
EBITDA
| 9,544.311 | 9,616.621 | 12,632.048 | 4,246.501 | 3,017.297 | 1,877.982 | 620.516 | 128.878 | 281.362 | 220.476 | 228.843 | 209.059 | 256.429 | 321.316 | 275.403 | 235.841 | 190.453 |
EBITDA Ratio
| 0.181 | 0.251 | 0.412 | 0.28 | 0.285 | 0.359 | 0.462 | 0.289 | 0.395 | 0.275 | 0.293 | 0.273 | 0.408 | 0.436 | 0.456 | 0.4 | 0.387 |